Dorzagliatin (HMS5552), a novel dual-acting glucokinase activator, improves glycaemic control and pancreatic β-cell function in patients with type 2 diabetes: A 28-day treatment study using biomarker-guided patient selection

2018 ◽  
Vol 20 (9) ◽  
pp. 2113-2120 ◽  
Author(s):  
Xiao-Xue Zhu ◽  
Da-Long Zhu ◽  
Xiao-Ying Li ◽  
Ya-Lin Li ◽  
Xiao-Wei Jin ◽  
...  
PLoS ONE ◽  
2015 ◽  
Vol 10 (8) ◽  
pp. e0133286 ◽  
Author(s):  
Søren Møller Madsen ◽  
Anne Cathrine Thorup ◽  
Kristian Overgaard ◽  
Per Bendix Jeppesen

2009 ◽  
Vol 33 (3) ◽  
pp. 257
Author(s):  
D. Williams-Herman ◽  
T. Seck ◽  
G. Golm ◽  
H. Wang ◽  
J. Johnson ◽  
...  

2002 ◽  
Vol 57 (1) ◽  
pp. 1-10 ◽  
Author(s):  
Shin-ichi Gorogawa ◽  
Yoshitaka Kajimoto ◽  
Yutaka Umayahara ◽  
Hideaki Kaneto ◽  
Hirotaka Watada ◽  
...  

2017 ◽  
Vol 9 (1) ◽  
pp. 383-394 ◽  
Author(s):  
Noriyuki Iwamoto ◽  
Akiko Matsui ◽  
Hirotaka Kazama ◽  
Tomonori Oura

Sign in / Sign up

Export Citation Format

Share Document